[Therapeutic effect of mucopolysaccharide polysulfate cream in prevention of postoperative scars]. 2018

Qing Zhang, and Yixin Zhou, and Lina Chen, and Yan Xu
Department of Dermatology, Second Xiangya Hospital, Central South University, Changsha 410011, China zhangqing3135@163.com.

To assess the therapeutic effect of mucopolysaccharide polysulfate cream in prevention of postoperative scars.
 Methods: One hundred postoperative patients were divided into an experimental group and a control group (each n=50). After stitch removal, the experimental group wiped mucopolysaccharide polysulfate cream, and the control group wiped urea cream. The scars of the two groups were evaluated by Vancouver Scar Scale (VSS) on the day of stitch removal and in the 4th, 8th, 12th, 16th, 20th, 24th, 28th, and 32th weeks during the treat process.
 Results: At the beginning of treatment, the total VSS scores in the experimental group were always lower than that in the control group (P<0.05). There was no difference between the two groups in the color scores at each time point of follow-up (P>0.05). Form the 20th week, the vascular distribution scores in the experimental group were lower than that in the control group (P<0.05). And the thickness and flexibility scores in the experimental group were lower at each time point of follow-up (P<0.05). There were no differences between the two groups in wounds in head, face, or neck in the total VSS scores and all index scores (P>0.05), and the total VSS scores in the experimental group, who had wounds in chest, shoulder, or back, or had wounds in waist, abdomen, or hip, or had wounds in extremity, were lower than that in the control group (P<0.05). The vascular distribution and thickness scores in the experimental group, who had wounds in chest, shoulder, or back, were better than that in the control group (P<0.05). 
 Conclusion: Wiping mucopolysaccharide polysulfate cream after operation as soon as possible can effectively prevent scar hyperplasia, and it is worth to be widely applied in clinic.

UI MeSH Term Description Entries
D011183 Postoperative Complications Pathologic processes that affect patients after a surgical procedure. They may or may not be related to the disease for which the surgery was done, and they may or may not be direct results of the surgery. Complication, Postoperative,Complications, Postoperative,Postoperative Complication
D002921 Cicatrix The fibrous tissue that replaces normal tissue during the process of WOUND HEALING. Scars,Cicatrization,Scar,Scarring
D006025 Glycosaminoglycans Heteropolysaccharides which contain an N-acetylated hexosamine in a characteristic repeating disaccharide unit. The repeating structure of each disaccharide involves alternate 1,4- and 1,3-linkages consisting of either N-acetylglucosamine (see ACETYLGLUCOSAMINE) or N-acetylgalactosamine (see ACETYLGALACTOSAMINE). Glycosaminoglycan,Mucopolysaccharides
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor
D014508 Urea A compound formed in the liver from ammonia produced by the deamination of amino acids. It is the principal end product of protein catabolism and constitutes about one half of the total urinary solids. Basodexan,Carbamide,Carmol
D016022 Case-Control Studies Comparisons that start with the identification of persons with the disease or outcome of interest and a control (comparison, referent) group without the disease or outcome of interest. The relationship of an attribute is examined by comparing both groups with regard to the frequency or levels of outcome over time. Case-Base Studies,Case-Comparison Studies,Case-Referent Studies,Matched Case-Control Studies,Nested Case-Control Studies,Case Control Studies,Case-Compeer Studies,Case-Referrent Studies,Case Base Studies,Case Comparison Studies,Case Control Study,Case Referent Studies,Case Referrent Studies,Case-Comparison Study,Case-Control Studies, Matched,Case-Control Studies, Nested,Case-Control Study,Case-Control Study, Matched,Case-Control Study, Nested,Case-Referent Study,Case-Referrent Study,Matched Case Control Studies,Matched Case-Control Study,Nested Case Control Studies,Nested Case-Control Study,Studies, Case Control,Studies, Case-Base,Studies, Case-Comparison,Studies, Case-Compeer,Studies, Case-Control,Studies, Case-Referent,Studies, Case-Referrent,Studies, Matched Case-Control,Studies, Nested Case-Control,Study, Case Control,Study, Case-Comparison,Study, Case-Control,Study, Case-Referent,Study, Case-Referrent,Study, Matched Case-Control,Study, Nested Case-Control
D063465 Skin Cream A water-soluble medicinal preparation applied to the skin. Dermal Cream,Skin Lotion,Cream, Dermal,Cream, Skin,Creams, Dermal,Creams, Skin,Dermal Creams,Lotion, Skin,Lotions, Skin,Skin Creams,Skin Lotions

Related Publications

Qing Zhang, and Yixin Zhou, and Lina Chen, and Yan Xu
November 2023, Journal of cosmetic dermatology,
Qing Zhang, and Yixin Zhou, and Lina Chen, and Yan Xu
November 1974, Arzneimittel-Forschung,
Qing Zhang, and Yixin Zhou, and Lina Chen, and Yan Xu
May 2004, Journal of pharmacological sciences,
Qing Zhang, and Yixin Zhou, and Lina Chen, and Yan Xu
December 1992, Annals of the New York Academy of Sciences,
Qing Zhang, and Yixin Zhou, and Lina Chen, and Yan Xu
March 1973, International surgery,
Qing Zhang, and Yixin Zhou, and Lina Chen, and Yan Xu
January 2021, Frontiers in medicine,
Qing Zhang, and Yixin Zhou, and Lina Chen, and Yan Xu
February 2022, Pharmaceuticals (Basel, Switzerland),
Qing Zhang, and Yixin Zhou, and Lina Chen, and Yan Xu
March 1987, Arzneimittel-Forschung,
Qing Zhang, and Yixin Zhou, and Lina Chen, and Yan Xu
January 2011, Arzneimittel-Forschung,
Qing Zhang, and Yixin Zhou, and Lina Chen, and Yan Xu
January 1987, Annals of clinical research,
Copied contents to your clipboard!